ABRAXANE (Abraxis BioScience, LLC)
Welcome to the PulseAid listing for the ABRAXANE drug offered from Abraxis BioScience, LLC. This Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Abraxis BioScience, LLC |
| NON-PROPRIETARY NAME: | Paclitaxel |
| SUBSTANCE NAME: | PACLITAXEL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2005-02-10 |
| END MARKETING DATE: | 0000-00-00 |
ABRAXANE HUMAN PRESCRIPTION DRUG Details:
| Item Description | ABRAXANE from Abraxis BioScience, LLC |
| LABELER NAME: | Abraxis BioScience, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/20mL) |
| START MARKETING DATE: | 2005-02-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68817-134_8b78c8ab-6766-4120-8213-eaa30731d3e4 |
| PRODUCT NDC: | 68817-134 |
| APPLICATION NUMBER: | NDA021660 |
Other PACLITAXEL Pharmaceutical Manufacturers / Labelers:
